相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria
A. C. Ford et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Review article: the economic impact of the irritable bowel syndrome
C. Canavan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal Symptom Scales
Brennan M. R. Spiegel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Probiotics reduce symptoms of antibiotic use in a hospital setting: A randomized dose response study
Arthur C. Ouwehand et al.
VACCINE (2014)
Irritable bowel syndrome: A clinical review
Rosa L. S. Soares
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine
Lekha Saha
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome
J. Konig et al.
BENEFICIAL MICROBES (2014)
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide
A. P. S. Hungin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments
Stefan Mueller-Lissner
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Magnus Simren et al.
GUT (2013)
A randomized, double-blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifidobacterium lactis CNCM I-2494 in healthy women reporting minor digestive symptoms
P. Marteau et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2013)
The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤50 years of age
Laura Rindom Krogsgaard et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Canadian Digestive Health Foundation Public Impact Series 3: Irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact
Richard N. Fedorak et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Longitudinal direct medical costs associated with constipation in women
R. S. Choung et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
'Gut health': a new objective in medicine?
Stephan C. Bischoff
BMC MEDICINE (2011)
Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients With Functional Bowel Disorders A Double-blind Study
Tamar Ringel-Kulka et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Direct Medical Costs of Constipation From Childhood to Early Adulthood: A Population-based Birth Cohort Study
Rok Seon Choung et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2011)
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation.
Mark Pimentel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults
Philip A. Waller et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Guidance on the scientific requirements for health claims related to gut and immune function EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
Carlo Agostoni et al.
EFSA JOURNAL (2011)
Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID
Lin Chang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Dose-Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile-Associated Diarrhea Prophylaxis in Adult Patients
Xing Wang Gao et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Evolution of Clinical Trials for Irritable Bowel Syndrome: Issues in End Points and Study Design
Ann Marie Trentacosti et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Validation of Symptom-Based Diagnostic Criteria for Irritable Bowel Syndrome: A Critical Review
William E. Whitehead et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Is Adequate Relief Fatally Flawed or Adequate as an End Point in Irritable Bowel Syndrome?
Michael Camilleri
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study
Denis Guyonnet et al.
BRITISH JOURNAL OF NUTRITION (2009)
Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults
C. N. Larsen et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2006)
Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome
Peter J. Whorwell et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Design of treatment trials for functional gastrointestinal disorders
E. Jan Irvine et al.
GASTROENTEROLOGY (2006)
Consensus report: clinical trial guidelines for pharmacological treatment of irritable bowel syndrome
E Corazziari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
International physical activity questionnaire:: 12-country reliability and validity
CL Craig et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2003)
Subject's Global Assessment of Relief:: An appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials
S Müller-Lissner et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
分享论文
